Form 4 for CSTL CASTLE BIOSCIENCES INC
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001447362-23-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | CSTL | Juvenal Tobin W | Chief Commercial Off | M - OptEx | $2.39 | +6,173 | 22.1K | +39% | +$14.8K |
| D | 2023-03-03 | 2023-03-01 | CSTL | Juvenal Tobin W | Chief Commercial Off | M - OptEx | $0.00 | -6,173 | 3,301 | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 6,173 | $2.39 | 22,092 | D | — | — | (F1) Includes 880 shares acquired on February 28, 2023, under the Issuer's employee stock purchase plan. |
| 2 | Derivative | Stock option (right to buy) | 2023-03-01 | M | D | 6,173 | $0.00 | 3,301 | D | $2.39 · — to 2028-05-09 | 6,173 Common Stock | (F3) The shares subject to the option are fully vested. |